NeuroSearch News
Most Popular NeuroSearch Story
Neurosearch shares soar on promising Ph3 Huntington's data
Investors swiftly bid up the value of Neurosearch (NEUR) shares by a whopping 81 percent after hearing that the Danish biotech's Phase III trial of a new drug for Huntington's disease demonstrated Read more...
Latest Headlines
- September 28, 2011
- January 11, 2011
- February 3, 2010
- August 17, 2009
- March 3, 2009
- February 17, 2009
- February 11, 2009
- October 24, 2008
- September 17, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
